Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
- 16 November 1995
- journal article
- clinical trial
- Published by Massachusetts Medical Society in The New England Journal of Medicine
- Vol. 333 (20), 1301-1308
- https://doi.org/10.1056/nejm199511163332001
Abstract
Lowering the blood cholesterol level may reduce the risk of coronary heart disease. This double-blind study was designed to determine whether the administration of pravastatin to men with hypercholesterolemia and no history of myocardial infarction reduced the combined incidence of nonfatal myocardial infarction and death from coronary heart disease.Keywords
This publication has 21 references indexed in Scilit:
- Screening experience and baseline characteristics in the West of Scotland coronary prevention studyThe American Journal of Cardiology, 1995
- Pravastatin, lipids, and atherosclerosis in the carotid arteries (PLAC-II)The American Journal of Cardiology, 1995
- Effects of pravastatin in patients with serum total cholesterol levels from 5.2 to 7.8 mmol/liter (200 to 300 mg/dl) plus two additional atherosclerotic risk factorsThe American Journal of Cardiology, 1993
- Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)JAMA, 1993
- Once‐daily pravastatin in patients with primary hypercholesterolemia: A dose‐response studyClinical Cardiology, 1991
- A new epidemiologic classification system for interim myocardial infarction from serial electrocardiographic changesThe American Journal of Cardiology, 1989
- Blood lipid concentrations and other cardiovascular risk factors: distribution, prevalence, and detection in BritainBMJ, 1988
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaThe New England Journal of Medicine, 1987
- The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol loweringJAMA, 1984
- The Lipid Research Clinics Coronary Primary Prevention Trial results. I. Reduction in incidence of coronary heart diseaseJAMA, 1984